Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin

Biological Psychiatry

Volumn 80, Issue 10, 2016, Pages 736-742

  Raskind, Murray A ^a,b   Millard, Steven P ^a   Petrie, Eric C ^a   Peterson, Kris ^c   Williams, Tammy ^c   Hoff, David J ^a   Hart, Kimberly ^a   Holmes, Hollie ^a,b   Hill, Jeffrey ^c   Daniels, Colin ^c   Hendrickson, Rebecca ^a   Peskind, Elaine R ^a,b  

^a Veterans Administration Northwest Network   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

Biomarker; Blood pressure; Military; Noradrenergic; Posttraumatic stress disorder (PTSD); Prazosin; Treatment response

Indexed keywords

PRAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENERGIC SYSTEM; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SOLDIER; STANDING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT RESPONSE; COMBAT DISORDERS; DRUG EFFECTS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; BIOMARKERS; BLOOD PRESSURE; COMBAT DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; OUTCOME ASSESSMENT (HEALTH CARE); PRAZOSIN; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 84994491901     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.03.2108     Document Type: Article

References (33)

1. 1 Raskind, M.A., Peskind, E.R., Kanter, E.D., Petrie, E.C., Radant, A., Thompson, C.E., et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study. Am J Psychiatry 160 (2003), 371–373.
2. 2 Raskind, M.A., Peskind, E.R., Hoff, D.J., Hart, K.L., Holmes, H.A., Warren, D., et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 61 (2007), 928–934.
3. 3 Taylor, F.B., Martin, P., Thompson, C., Williams, J., Mellman, T.A., Gross, C., et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biol Psychiatry 63 (2008), 629–632.
4. 4 Germain, A., Richardson, R., Moul, D.E., Mammen, O., Haas, G., Forman, S.D., et al. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res 72 (2012), 89–96.
5. 5 Raskind, M.A., Peterson, K., Williams, T., Hoff, D.J., Hart, K., Holmes, H., et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afgahnistan. Am J Psychiatry 170 (2013), 1003–1010.
6. 6 Ahmadpanah, M., Sabzeiee, P., Hosseini, S.M., Torabian, S., Haghighi, M., Jahangard, L., et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology 69 (2014), 235–242.
7. 7 Guy W (1976): The Clinical Global Impression Scale. In: ECDEU Assessment Manual for Psychopharmacology Revised. Rockville, MD: US Dept of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 218–222.
8. 8 Pine, D.S., Leibenluft, E., Biomarkers with a mechanistic focus. JAMA Psychiatry 72 (2015), 633–634.
9. 9 Southwick, S.M., Morgan, C.A. 3rd, Bremner, A.D., Grillon, C.G., Krystal, J.H., Nagy, L.M., et al. Noradrenergic alterations in posttraumatic stress disorder. Ann N Y Acad Sci 821 (1997), 125–141.
10. 10 Mellman, T.A., Kumar, A., Kulick-Bell, R., Kumar, M., Nolan, B., Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 38 (1995), 174–179.
11. 11 Geracioti, T.D. Jr, Baker, D.G., Ekhator, N.N., West, S.A., Hill, K.K., Bruce, A.B., et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 158 (2001), 1227–1230.
12. 12 Westfall, T.C., Westfall, D.P., Adrenergic agonists and antagonists. Hardman, J., Limbird, L., Molinoff, P., Ruddon, R., Gilman, A., (eds.) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed., 2006, McGraw-Hill, New York.
13. 13 Menkes, D.B., Baraban, J.M., Aghajanian, G.K., Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmiedebergs Arch Pharmacol 317 (1981), 273–275.
14. 14 Pickworth, W.B., Sharpe, L.G., Nozaki, M., Martin, W.R., Sleep suppression induced by intravenous and intraventricular infusions of methoxamine in the dog. Exp Neurol 57 (1977), 999–1011.
15. 15 Berridge, C.W., The locus ceruleus-noradrenergic system and stress: Implications for posttraumatic stress disorder. Shiromani, P., Keane, T., LeDoux, J.E., (eds.) Post-Traumatic Stress Disorder: Basic Science and Clinical Practice, 2009, Humana Press, New York, 213–230.
16. 16 Arnsten, A.F., Raskind, M.A., Taylor, F.B., Connor, D.F., The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol Stress 1 (2015), 89–99.
17. 17 Samuels, E.R., Szabadi, E., Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol 6 (2008), 254–285.
18. 18 Reid, J.L., Alpha-adrenergic receptors and blood pressure control. Am J Cardiol 57 (1986), 6e–12e.
19. 19 Blake, D.D., Weathers, F.W., Nagy, L.M., Kaloupek, D.G., Gusman, F.D., Charney, D.S., et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8 (1995), 75–90.
20. 20 Buysse, D.J., Reynolds, C.F.I., Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric research and practice. Psychiatry Res 28 (1989), 193–213.
21. 21 Pinheiro, J.C., Bates, D.M., Mixed-Effects Models in S and S-PLUS. 2000, Springer, New York.
22. 22 R Development Core Team. A Language and Environment for Statistical Computing. 2014, R Foundation for Statistical Computing, Vienna, Austria.
23. 23 Pinheiro, J.C., Bates, D.M., DebRoy, S., Sarkar, D., Core Team, R., nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-117. 2014, R Foundation for Statistical Computing, Vienna, Austria.
24. 24 Southwick, S.M., Krystal, J.H., Bremner, J.D., Morgan, C.A. 3rd, Nicolaou, A.L., Nagy, L.M., et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 54 (1997), 749–758.
25. 25 Arnsten, A.F., Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11 (1997), 151–162.
26. 26 Hilakivi, I., Leppavuori, A., Effects of methoxamine, an alpha-1 adrenoceptor agonist, and prazosin, an alpha-1 antagonist, on the stages of the sleep-waking cycle in the cat. Acta Physiol Scand, 120, 1984 363–172.
27. 27 Pellejero, T., Monti, J.M., Baglietto, J., Jantos, H., Pazos, S., Cichevski, V., et al. Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat. Sleep 7 (1984), 365–372.
28. 28 Kleinlogel, H., Effects of the selective alpha 1-adrenoceptor blocker prazosin on EEG sleep and waking stages in the rat. Neuropsychobiology 21 (1989), 100–103.
29. 29 Woodward, S.H., Arsenault, N.J., Murray, C., Bliwise, D.L., Laboratory sleep correlates of nightmare complaint in PTSD inpatients. Biol Psychiatry 48 (2000), 1081–1087.
30. 30 Walker, M.P., van der Helm, E., Overnight therapy? The role of sleep in emotional brain processing. Psychol Bull 135 (2009), 731–748.
31. 31 Yehuda, R., Bierer, L.M., Sarapas, C., Makotkine, I., Andrew, R., Seckl, J.R., Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology 34 (2009), 1304–1313.
32. 32 Nijdam, M.J., van Amsterdam, J.G., Gersons, B.P., Olff, M., Dexamethasone-suppressed cortisol awakening response predicts treatment outcome in posttraumatic stress disorder. J Affect Disord 184 (2015), 205–208.
33. 33 O'Toole, B.I., Catts, S.V., Trauma, PTSD, and physical health: An epidemiological study of Australian Vietnam veterans. J Psychosom Res 64 (2008), 33–40.